Nitric oxide: Not just a negative inotrope

European Journal of Heart Failure

Volumn 3, Issue 5, 2001, Pages 527-534

  Sarkar, David ^a,b   Vallance, Patrick ^b   Harding, Sian E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Myocardium; Nitric oxide; Nitric oxide synthase isoform

Indexed keywords

ARGININE; CITRULLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TETRAHYDROBIOPTERIN;

ANIMAL CELL; BIOSYNTHESIS; CATALYSIS; HEART CONTRACTION; HEART DISEASE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INOTROPISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

DEPRESSION, CHEMICAL; ENDOCARDIUM; ENZYME INDUCTION; HUMANS; MYOCARDIAL CONTRACTION; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; STIMULATION, CHEMICAL;

EID: 0035740640     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00163-5     Document Type: Review

References (72)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. The L-arginine nitric oxide pathway
3. Regulation of the biosynthesis of nitric oxide
4. Natural resistance and nitric oxide
5. Nitric oxide attenuates cardiac myocyte contraction
6. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia
7. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
8. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture
9. Endotoxin and cytokines induce direct cardiodepressive effect in mammalian cardiomyocytes via induction of nitric oxide synthase
10. Nitric oxide synthesis in cultured endocardial cells of the pig
11. Factors released from the endocardium of the ferret and the pig modulate myocardial contraction
12. Nitric oxide dependent parasympathetic signalling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes
13. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes
14. Genetic expression of endothelial nitric oxide synthase in human atrial myocardium
15. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences
16. The negative inotropic effect of beta-3-adrenergic stimulation is mediated by activation of nitric oxide synthase pathway in human ventricle
17. NO synthase activity in the human myocardium
18. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease
19. Expression of inducible nitric oxide synthase in human heart failure
20. Inducible nitric oxide synthase and tumour necrosis factor-alpha in myocardium in human dilated cardiomopathy
21. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart
22. Increased nitric oxide production in heart failure
23. Heterogenous expression and activity of endothelial and inducible nitric oxide synthase in end-stage human heart failure
24. Inducible nitric oxide synthase (iNOS) in the human heart: Expression and localization in congestive heart failure
25. Expression of inducible nitric oxide synthase in failing and non-failing human hearts
26. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction in the left ventricle
27. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy
28. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure
29. Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNgamma, and LPS
30. Nitric oxide as an antimicrobial agent: Does NO always mean NO?
31. An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart
32. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle
33. Paracrine coronary endothelial control of left ventricular function in humans
34. NO cardiac diastolic function
35. Paracrine and autocrine effects of nitric oxide on myocardial function
36. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion
37. Myocardial relaxant effect of exogenous nitric oxide in the isolated ejecting heart
38. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart
39. Mechanical transduction of nitric oxide synthesis in the beating heart
40. Nitro-glycerine as a remedy for angina pectoris
41. Chemistry, analysis and biological roles of S-nitrosothiols
42. S-Nitosothiols: A class of nitric oxidedonor drugs
43. Nitric oxide/nucleophilic complexes: A unique class of nitric oxide-based vasodilators
44. 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms
45. S-Nitrosoglutathione inhibits platelet activation in vitro and in vivo
46. Effects of S-nitroso-glutathione in the human forearm circulation: Evidence for selective inhibition of platelet activation
47. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty
48. S-Nitrosoglutathione reduces the rate of embolization in humans
49. S-Nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo
50. Low increases in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes
51. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
52. The new NO donor SPM3672 increases cGMP and improves contraction in rat isolated cardiomyocytes and isolated heart
53. Myocardial contractile response to nitric oxide and cGMP
54. Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts
55. Inotropic effect of glyceryl trinitrate and spontaneous NO donors in the dog heart
56. Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of frog heart
57. Activation of distinct cAMP dependent pathways by nitric oxide in cardiac myocytes
58. Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart
59. Inhibition of nitric oxide synthase and soluble guanyl cyclase induces cardiodepressive effects in normal rats
60. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation
61. Positive inotropic effects of NO donors in isolated guinea-pig and human cardiomyocytes independent of NO species and cyclic nucleotides
62. Detection of guanyl cyclase in mammalian tissues
63. Soluble guanyl cyclse from bovine lung: Activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states
64. Distinct and specific functions of cGMP dependent protein kinases
65. Structure and function of cyclic nucleotide-gated channels
66. Structure, localization and regulation of cGMP-inhibited phosphodiesterase (PDE 3)
67. Tailoring cAMP-signalling responses through isoform multiplicity
68. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase
69. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation
70. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation
71. Research of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide
72. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy